【山东新华制药股份(00719.HK):阿司匹林肠溶片新增规格及通过仿制药一致性评价】山东新华制药股份(00719.HK)发布公告,近日,公司收到国家药品监督管理局核准签发的阿司匹林肠溶片(100mg)的《药品补充申请批准通知书》,本品通过仿制药质量和疗效一致性评价。

金融界
Yesterday
山东新华制药股份(00719.HK)发布公告,近日,公司收到国家药品监督管理局核准签发的阿司匹林肠溶片(100mg)的《药品补充申请批准通知书》,本品通过仿制药质量和疗效一致性评价。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10